Ingevity Corp Files 8-K on Security Holder Votes
Ticker: NGVT · Form: 8-K · Filed: 2024-04-23T00:00:00.000Z
Sentiment: neutral
Topics: corporate-governance, financial-reporting, sec-filing
Related Tickers: NGVT
TL;DR
INGEVITY CORP FILED AN 8-K ON VOTES AND FINANCIALS.
AI Summary
On April 23, 2024, Ingevity Corporation filed an 8-K report indicating that matters were submitted to a vote of security holders. The filing also includes financial statements and exhibits. The company, incorporated in Delaware, is based in North Charleston, South Carolina.
Why It Matters
This filing provides updates on corporate governance and financial reporting for Ingevity Corporation, which is important for investors to understand the company's operational and voting activities.
Risk Assessment
Risk Level: low — This is a routine filing reporting on security holder votes and financial statements, not indicating any immediate operational or financial distress.
Key Numbers
- 001-37586 — SEC File Number (Identifies the company's filing with the SEC.)
- 47-4027764 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Ingevity Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- North Charleston, South Carolina (location) — Principal business address
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary business of Ingevity Corporation?
Ingevity Corporation is in the CHEMICALS & ALLIED PRODUCTS industry, SIC code 2800.
When was this 8-K report filed?
The report was filed on April 23, 2024.
What is Ingevity Corporation's fiscal year end?
Ingevity Corporation's fiscal year ends on December 31st.
Where is Ingevity Corporation's principal executive office located?
The principal executive office is located at 4920 O'Hear Avenue, Suite 400, North Charleston, South Carolina 29405.
Filing Stats: 692 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2024-04-23 17:06:48
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange
Filing Documents
- ngvt-20240423.htm (8-K) — 50KB
- ngvt-20240423_g1.jpg (GRAPHIC) — 143KB
- 0001653477-24-000042.txt ( ) — 463KB
- ngvt-20240423.xsd (EX-101.SCH) — 2KB
- ngvt-20240423_lab.xml (EX-101.LAB) — 21KB
- ngvt-20240423_pre.xml (EX-101.PRE) — 12KB
- ngvt-20240423_htm.xml (XML) — 3KB
07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. On April 23, 2024, Ingevity Corporation (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"), at which the Company's stockholders voted on the four proposals identified below. Each of the proposals is described in more detail in the Company's definitive proxy statement, which was filed with the U.S. Securities and Exchange Commission on March 11, 2024. There were 36,247,546 shares of the Company's common stock issued and outstanding on the record date and entitled to vote at the Annual Meeting, and 34,260,140 shares (94.51%) were represented in person or by proxy at the Annual Meeting, which number constituted a quorum. The final voting results for each proposal voted upon at the Annual Meeting are described below. 1. Election of the nine (9) director nominees listed below, each for a one-year term or until his or her successor is duly elected and qualified: FOR AGAINST ABSTAIN BROKER NON-VOTE Jean S. Blackwell 31,907,920 545,050 28,499 1,778,671 Luis Fernandez-Moreno 31,509,045 953,278 19,146 1,778,671 John C. Fortson 31,969,854 492,148 19,467 1,778,671 Diane H. Gulyas 31,908,052 555,388 18,029 1,778,671 Bruce D. Hoechner 31,770,265 691,982 19,222 1,778,671 Frederick J. Lynch 32,003,156 459,229 19,084 1,778,671 Karen G. Narwold 32,102,477 357,911 21,081 1,778,671 Daniel F. Sansone 31,970,362 491,886 19,221 1,778,671 Benjamin G. (Shon) Wright 32,097,099 364,877 19,493 1,778,671 2. Approval, on a non-binding, advisory basis, of the compensation of our named executive officers. FOR AGAINST ABSTAIN BROKER NON-VOTE 31,520,246 903,967 57,256 1,778,671 3. Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2024. FOR AGAINST ABSTAIN 34,090,470 146,126 23,544 4. Approval of amendment to the Company's Certificate of Incorporation to provide for the exculpation of certain officer
01. FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit No. Description of Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /S/ STACY L. COZAD Stacy L. Cozad Executive Vice President, General Counsel and Secretary Date: April 23, 2024